Merck makes a giant transfer into new most cancers therapies with a $6.7 billion buyout deal
Merck to spend $6.7 billion to buy Terns Pharmaceuticals, which is developing an oral treatment for leukemia.
Trending
- EXCLUSIVE: Lockdown 2.0 Imminent – 10 Level Plan Revealed | Every day Pulse
- Tata Communications unveils self-healing community | JP
- Eric Swalwell Marketing campaign Funneled Over $300K to Felony Protection Attorneys, Filings Present
- Infants are Killed in Late-Time period Abortions Throughout America Simply Like Kermit Gosnell Did
- High Pollster Reveals Frontrunner In Texas GOP Senate Main
- Fantasy baseball: Learn the warning label earlier than drafting these guys
- SCOTUS seems poised to permit Trump to dam asylum claims at border crossings
- Indra groups up with Hanwha for Spain’s $5.3 billion artillery order
- REPORT: British Navy Anticipated To Lead Efforts To Re-Open Strait Of Hormuz
- Sorry Jensen Huang, we’ve not ‘achieved AGI’ — however the AI milestone is not the be-all and end-all